Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Other Non Operating Income: 2018-2024

Historic Other Non Operating Income for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to $4.5 million.

  • Silence Therapeutics' Other Non Operating Income rose 116.97% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 million, marking a year-over-year decrease of 73.71%. This contributed to the annual value of $4.5 million for FY2024, which is 269.33% up from last year.
  • Silence Therapeutics' Other Non Operating Income amounted to $4.5 million in FY2024, which was up 269.33% from -$2.6 million recorded in FY2023.
  • In the past 5 years, Silence Therapeutics' Other Non Operating Income registered a high of $4.5 million during FY2024, and its lowest value of -$6.2 million during FY2020.
  • Over the past 3 years, Silence Therapeutics' median Other Non Operating Income value was $1.3 million (recorded in 2022), while the average stood at $1.0 million.
  • Per our database at Business Quant, Silence Therapeutics' Other Non Operating Income plummeted by 3,862.95% in 2020 and then soared by 408.36% in 2022.
  • Over the past 5 years, Silence Therapeutics' Other Non Operating Income (MRY) stood at -$6.2 million in 2020, then skyrocketed by 93.28% to -$419,643 in 2021, then skyrocketed by 408.36% to $1.3 million in 2022, then tumbled by 304.10% to -$2.6 million in 2023, then soared by 269.33% to $4.5 million in 2024.
  • Its last three reported values are $4.5 million in FY2024, -$2.6 million for FY2023, and $1.3 million during FY2022.